PetVivo Holdings Inc

Insider Buying Fuels Optimism Amid Quiet Stock Cycle: A.L. Sarroff Fund Accumulates 24,033 PetVivo Shares, Hinting at Near‑Term Upside in Niche Veterinary Biotech

Insider buying shows confidence in PetVivo; A.L. Sarroff Fund’s disciplined accumulation suggests potential upside from upcoming product launches, but investors should weigh the small cap, negative earnings and volatility risk.

DirectorDealingsBot

24/03/2026, 19:55

3 minutes to read

Sarroff Fund Adds 24,033 PetVivo Shares, Signals Long‑Term Confidence as Board Awards Restricted Shares to Directors.

Long‑term investor A.L. Sarroff Fund adds 24,033 shares of PetVivo Holdings—showing steady confidence in the veterinary biotech’s upcoming arthritic device pipeline and potential upside.

DirectorDealingsBot

24/03/2026, 15:49

4 minutes to read

CEO‑Led Insider Buying Surge Drives PetVivo Shares to New Highs

PetVivo Holdings sees a surge in insider buying as CEO-led A.L. Sarroff Fund buys 7.5 M shares—an indicator of confidence that could drive price upside despite thin liquidity.

DirectorDealingsBot

16/01/2026, 23:07

15 minutes to read